FIELD: medicine.
SUBSTANCE: in the present invention, a method for the treatment of overweight or obesity is proposed, including the administration of a pharmaceutical composition containing therapeutically effective amount of naltrexone or its pharmaceutically acceptable salt and bupropion or its pharmaceutically acceptable salt, providing availability control when taken with food, which does not contain high-fat food.
EFFECT: obtaining a method for the treatment of overweight or obesity.
8 cl, 1 dwg, 4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INCREASE OF DRUG BIDOSTASTICITY AT THERAPY BY NALTREXONE | 2011 |
|
RU2640561C2 |
| METHODS FOR REDUCING BINGE OR COMPULSIVE EATING | 2011 |
|
RU2620913C2 |
| COMPOSITIONS AND METHODS FOR REDUCING SERIOUS ADVERSE CARDIOVASCULAR EVENTS | 2014 |
|
RU2711638C2 |
| METHODS OF WEIGHT LOSS THERAPY IN PATIENTS WITH DOMINANT DEPRESSION (VERSIONS) | 2011 |
|
RU2616496C2 |
| METHODS FOR WEIGHT LOSS THERAPY IN PATIENTS WITH DOMINANT DEPRESSION | 2011 |
|
RU2788450C2 |
| LAYERED PHARMACEUTICAL COMPOSITIONS | 2007 |
|
RU2452471C2 |
| OXICODON AND NALOXON-CONTAINING PHARMACEUTICAL COMPOSITIONS WITH INSTANT RELEASE | 2010 |
|
RU2522212C2 |
| REGIMEN FOR TREATMENT WITH 2-AMINO-1-(2-(4-FLUOROPHENYL)-3-(4-FLUOROPHENYLAMINO)-8,8-DIMETHYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZINE-7 (8H)-YL)ETHENONE AND ITS COMBINATIONS | 2018 |
|
RU2791466C2 |
| COMPOSITIONS, DEVICES AND METHODS FOR THE TREATMENT OF ALCOHOL DEPENDENCE | 2017 |
|
RU2767062C2 |
| CRF1 RECEPTOR ANTAGONIST, PHARMACEUTICAL FORMULATIONS AND SOLID FORMS FOR TREATING CONGENITAL ADRENAL HYPERPLASIA | 2019 |
|
RU2824490C2 |
